CDK9 Antagonist-1
CDK9 Antagonist-1 (compounds 11c) is a potent and selective PROTAC-based CDK9 degrader, demonstrating an IC50 of 17 μM in MCF-7 breast cancer cells. This compound, which utilizes a wogonin-derived linker to engage the CRBN E3 ligase, is a valuable chemical probe for investigating CDK9-dependent transcription in oncology and molecular pharmacology research.
Product Specifications
Field of Research
Epigenetics & Chromatin; Pharmacology & Drug Discovery
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
